Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$513.7K
24.57K shares
What this filing means
METZGER MICHAEL A plans to sell 24.57K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $513.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/9/2026ACC: 0001959173-26-000773
Officer· President and COO
Since Feb 2019
24.57K
Shares to sell
$513.7K
Approx. market value
17.16K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/6/2026
17.16KTotal acquired17.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/6/2026 | Restricted Stock Vesting Compensation | 17.16K | — |
| Total | 17.16K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.41K
Market value
$152.8K
2/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
17.16K
Market value
$360.8K
2/9/2026
Total
Units
24.57K
Value
$513.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/6/2026 | 7.41K | $152.8K | — | Completed |
| Planned — Approximate Date | ||||
2/9/2026 | 17.16K | $360.8K | NASDAQ | Planned |
| Total | 24.57K | $513.7K | ||